Normal view MARC view ISBD view

Safety and efficacy of infliximab in a patient with active WHO class IV lupus nephritis.

Hayat, Sawsan J

Safety and efficacy of infliximab in a patient with active WHO class IV lupus nephritis. [electronic resource] - Clinical rheumatology Jun 2007 - 973-5 p. digital

Publication Type: Case Reports; Journal Article

ISSN: 0770-3198

Standard No.: 10.1007/s10067-006-0219-0 doi

Subjects--Topical Terms:
Adult
Antibodies, Monoclonal--therapeutic use
Antirheumatic Agents--therapeutic use
Female
Humans
Infliximab
Lupus Nephritis--drug therapy
Remission Induction
Tumor Necrosis Factor-alpha--antagonists & inhibitors

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)